Business Model and Revenue Projections - The company will hold a virtual roadshow webinar to discuss its business operations and recent updates, including an overview of its business model and recent milestone achievements [1][2] - The company recently expanded its exclusive distribution agreement with Zimmer Biomet, one of the world's largest medical device manufacturers [2] - Product revenue grew by 77% to $3.5 million in fiscal year 2024, and is expected to increase to between $8 and $10 million in fiscal year 2025, representing a growth of 132% to 190% [2] Webinar Details - The webinar will include a presentation followed by a Q&A session, accessible via webcast or dial-in numbers [3] - The webinar is scheduled for Thursday, January 9, 2025, at 11:00 a.m. Eastern Standard Time [3] - A playback of the call will be available through January 23, 2025 [4] Company Overview - NeuroOne Medical Technologies Corporation is focused on developing minimally invasive and hi-definition solutions for EEG recording, brain stimulation, and ablation for patients with neurological disorders such as epilepsy, Parkinson's disease, and chronic pain [5] - The company is also exploring applications in other areas including depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence [5] Forward-Looking Statements - The press release contains forward-looking statements regarding the company's future performance, including expectations for significant product revenue growth and margin expansion in fiscal year 2025 [6] - These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially [6][7]
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST